| 000 | 01419 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250516033725.0 | ||
| 264 | 0 | _c20111205 | |
| 008 | 201112s 0 0 eng d | ||
| 022 | _a1873-4294 | ||
| 024 | 7 |
_a10.2174/156802611795589566 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDanilenko, Valery N | |
| 245 | 0 | 0 |
_aBacterial eukaryotic type serine-threonine protein kinases: from structural biology to targeted anti-infective drug design. _h[electronic resource] |
| 260 |
_bCurrent topics in medicinal chemistry _c2011 |
||
| 300 |
_a1352-69 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xchemical synthesis |
| 650 | 0 | 4 |
_aBacteria _xcytology |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 |
_aEukaryotic Cells _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xchemical synthesis |
| 650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aOsolodkin, Dmitry I | |
| 700 | 1 | _aLakatosh, Sergey A | |
| 700 | 1 | _aPreobrazhenskaya, Maria N | |
| 700 | 1 | _aShtil, Alexander A | |
| 773 | 0 |
_tCurrent topics in medicinal chemistry _gvol. 11 _gno. 11 _gp. 1352-69 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/156802611795589566 _zAvailable from publisher's website |
| 999 |
_c20778624 _d20778624 |
||